DNA
#2995
Ginkgo Bioworks Holdings, Inc. Class A Common Stock
7.0 4 USD
+0.01%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+1.44%
Variación mensual
-13.19%
Variación en los últimos 6 meses
+2.77%
Cambio anual
-20.72%
Cierres anteriores
6.9 4
Open
7.0 1
Mínimo
6.9 6
Máximo
7.0 7
Volumen
450
Financials
- Market Capitalization 452.96 M
- Employee 485
- Founded 2008
- CEO Jason Kelly
- Website www.ginkgobioworks.com
- Headquarter Delaware, United States
- FIGI BBG00YPS1KY3
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-1.98
Relación precio/flujo de caja
4.57
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2985 |  GALT Galectin Therapeutics Inc. - Common Stock | 4.50 USD | +7.91% | +8.43% | +51.52% | +1.35% | 453.82 M USD | ||
| 2986 |  OCGN Ocugen, Inc. - Common Stock | 1.33 USD | 0.00% | -5.67% | +7.26% | +31.68% | 451.02 M USD | ||
| 3006 |  PRLD Prelude Therapeutics Incorporated - Common Stock | 5.44 USD | -0.91% | -17.07% | +16.99% | +385.71% | 434.13 M USD | ||
| 3007 |  BNTC Benitec Biopharma Inc. - Common Stock | 12.88 USD | +4.63% | 0.00% | +8.51% | -22.46% | 442.48 M USD |